BiotechTube
Home/MediLink Therapeutics/Steve Chin
SC

Steve Chin

CMO

MediLink Therapeutics

Therapeutic Areas

Oncology

MediLink Therapeutics Pipeline

DrugIndicationPhase
YL201Solid Tumors (SCLC, NPC)Phase 3
YL202Solid TumorsPhase 1
YL205Solid TumorsPhase 1
YL217Solid TumorsPhase 1
YL211Solid TumorsPhase 1
YL212Solid TumorsPhase 1
YL215Solid TumorsPhase 1
YL221Solid TumorsPhase 1

Leadership Team at MediLink Therapeutics

TX
Tony Xue
Chairman, Founder & CEO
JC
Jiaqiang Cai
Co-founder, CSO & Co-CEO
JL
Jason Li
CFO
WZ
Weichang Zhou
CTO
View full MediLink Therapeutics profile